Drug Shortage Report for ZERIT - CAP 20MG

Last updated on 2019-03-29 History
Report ID 55662
Drug Identification Number 02216094
Brand name ZERIT - CAP 20MG
Common or Proper name STAVUDINE
Company Name BRISTOL-MYERS SQUIBB CANADA
Active Ingredient(s) STAVUDINE
Strength(s) 20MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 1 BTL x 60
ATC code J05AF
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-03-25
Actual start date
Estimated end date 2019-03-25
Actual end date 2019-03-28
Shortage status Resolved
Updated date 2019-03-29
Company comments Product on allocation
Health Canada comments
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
MONTRÉAL (ST-LAURENT), QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v41 2019-03-29 French Compare
v40 2019-03-29 English Compare
v39 2019-03-26 English Compare
v38 2019-03-13 French Compare
v37 2019-03-13 English Compare
v36 2019-03-12 French Compare
v35 2019-03-12 English Compare
v34 2019-03-12 French Compare
v33 2019-03-04 French Compare
v32 2019-03-04 English Compare
v31 2019-03-01 English Compare
v30 2019-02-20 French Compare
v29 2019-02-20 English Compare
v28 2019-02-19 French Compare
v27 2019-02-19 English Compare
v26 2019-02-16 English Compare
v25 2019-02-01 French Compare
v24 2019-02-01 English Compare
v23 2019-02-01 English Compare
v22 2019-01-24 French Compare

Showing 1 to 20 of 41